Key facts
- Groupe Bruxelles Lambert filed SCHEDULE 13D/A for CONCENTRIX CORPORATION Common Stock, par value $0.0001 per share (CNXC).
- Disclosed ownership: 4.6%.
- Date of event: 29 Apr 2026.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FINPAR VI SA | 0.06% | 38,623 | 0 | 38,623 | /s/ Priscilla Maters - /s/ Xavier Likin | Priscilla Maters / Director - Xavier Likin / Director | |
| FINPAR V SA | 0.06% | 35,964 | 0 | 35,964 | /s/ Priscilla Maters - /s/ Xavier Likin | Priscilla Maters / Director - Xavier Likin / Director | |
| Sapiens S.ar.l. | 4.4% | 2,699,080 | 0 | 2,699,080 | /s/ Priscilla Maters - /s/ Serge Saussoy | Priscilla Maters / Director - Serge Saussoy / Director | |
| GBL Verwaltung S.A. | 4.4% | 2,699,080 | 0 | 2,699,080 | /s/ Priscilla Maters - /s/ Serge Saussoy | Priscilla Maters / Director - Serge Saussoy / Director | |
| Groupe Bruxelles Lambert | 4.6% | 2,773,667 | 0 | 2,773,667 | /s/ Priscilla Maters - /s/ Xavier Likin | Priscilla Maters / General Counsel - Xavier Likin / Chief Financial Officer | 0001179313 |
CIK / CUSIP context first